GlaxoSmithKline Pharmaceuticals Limited
GLAXO
株式のランク
#3633
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
株価
$27.56
時価総額
$4.67B
変化（1日）
-2.65%
変化（1年）
-11.55%
国
IN
取引 GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
カテゴリー
Healthcare
GlaxoSmithKline Pharmaceuticals Limited（GLAXO）の営業利益率
October 2026 時点の営業利益率 TTM: 32.54%
GlaxoSmithKline Pharmaceuticals Limited の最新の財務報告と株価によると、現在の営業利益率（TTM）は 32.54% です。2024 年末時点では 39.38% でした。
GlaxoSmithKline Pharmaceuticals Limited の営業利益率の履歴（2004 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 32.54% | -25.20% |
| 2025 | 43.50% | 10.46% |
| 2024 | 39.38% | 69.60% |
| 2023 | 23.22% | 8.10% |
| 2022 | 21.48% | 19.27% |
| 2021 | 18.01% | 6.88% |
| 2020 | 16.85% | -19.30% |
| 2019 | 20.88% | 14.22% |
| 2018 | 18.28% | 35.41% |
| 2017 | 13.50% | -19.59% |
| 2016 | 16.79% | -9.34% |
| 2015 | 18.52% | -8.95% |
| 2013 | 20.34% | -32.47% |
| 2012 | 30.12% | -22.75% |
| 2011 | 38.99% | -3.78% |
| 2010 | 40.52% | 1.55% |
| 2009 | 39.90% | -3.62% |
| 2008 | 41.40% | 6.10% |
| 2007 | 39.02% | 8.99% |
| 2006 | 35.80% | 11.32% |
| 2005 | 32.16% | 5.96% |
| 2004 | 30.35% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 49.72% | -98.47% |
US
|
|
| 25.70% | -99.21% |
US
|
|
| 29.32% | -99.10% |
US
|
|
| 16.65% | -99.49% |
US
|
|
| 26.59% | -99.18% |
CH
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。